CDEK
← Mechanisms of action

Tumor antigens

PROTEIN COMPLEX GROUPHomo sapiens

Drugs acting on this target (250)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
(pg13-a(f/k-f-sgsg-t2a-b (opt) (2g-1 tcr) retroviral vector-transduced lymphocyteImmunity, activeexperimentalGene therapyimmunity, active - tumor antigen
6mhpImmunity, activeexperimentalVaccineTumor antigens immunity, active
9 peptides from her-2/neu, cea, & ctaImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ad-isf35Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ad-magea3Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ad-sig-hmuc-1/ecdcd40l vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ad/l523sImmunity, activeexperimentalVaccineTumor antigens immunity, active
ad5-hgcc-padre vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ae37 + gm-csf vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
allo lmi vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
allogeneic gm-csf-secreting breast cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
allogeneic myeloma vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
allogeneic pancreatic tumor cells transfected with a gm-csf geneImmunity, activeexperimentalVaccineTumor antigens immunity, active
allogeneic tumor cell vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
allostimImmunity, activeexperimentalVaccineTumor antigens immunity, active
allovaxImmunity, activeexperimentalVaccineTumor antigens immunity, active
alpha (1,3) galactosyltransferase expressing allogeneic tumor cellsImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
alvac mart-1 vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
antiangiogenic peptide vaccine therapyImmunity, activeexperimentalVaccineTumor antigens immunity, active
apc8020Immunity, activeexperimentalVaccineimmunity, active - tumor antigen
autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
autologous fl vaccineImmunity, activeexperimentalCell therapyTumor antigens immunity, active
autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
belagenpumatucel-lImmunity, activeexperimentalVaccineTumor antigens immunity, active
bls_ils_e710cImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
bpx-101Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
cd40 ligand-expressing tumor cellsImmunity, activeexperimentalVaccineTumor antigens immunity, active
cdx1307Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
cg8123Immunity, activeexperimentalVaccineTumor antigens immunity, active
chadox1.5t4Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
colon kcc heptapeptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
cpg-activated, autologous tumor vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigen
crcl-allovaxImmunity, activeexperimentalVaccineTumor antigens immunity, active
crs-100Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
cv9103Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
cv9104Immunity, activeexperimentalVaccineTumor antigens immunity, active
dc vaccineImmunity, activeexperimentalCell therapyimmunity, active - tumor antigen
dc/rcc fusion vaccineImmunity, activeexperimentalCell therapyimmunity, active - tumor antigen
dc1 vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigen
dcvac/lucaImmunity, activeexperimentalVaccineTumor antigens immunity, active
dcvac/ovca in parallelImmunity, activeexperimentalCell therapyimmunity, active - tumor antigens
dendritic cell tumor fusion vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
dendritic cell vaccine for high risk ovarian cancer patientsImmunity, activeexperimentalVaccineTumor antigens immunity, active
dendritic cell-gp100-mart-1 antigen vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
dendritic cell-idiotype-keyhole limpet hemocyanin vaccineImmunity, activeexperimentalCell therapyTumor antigens immunity, active
dendritic cells - transfected with htert-, survivin- and tumor cell derived mrna + ex vivo t cell expansion and reinfusionImmunity, activeexperimentalCell therapyimmunity, active - tumor antigens
dendritic cells loaded with 17 antigensImmunity, activeexperimentalVaccineTumor antigens immunity, active
dpx-0907Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
dribblesImmunity, activeexperimentalVaccineTumor antigens immunity, active
drosophila-peptide pulsed melanoma-reactive autologous cd8+ pblImmunity, activeexperimentalVaccineTumor antigens immunity, active
e1m184vImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
e39 peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigen
egen-001Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
emepepimut-s (Stimuvax)Immunity, activeexperimentalVaccineimmunity, active - tumor antigen
ep-2101Immunity, activeexperimentalVaccineTumor antigens immunity, active
erc1671Immunity, activeexperimentalVaccineTumor antigens immunity, active
favldImmunity, activeexperimentalVaccineTumor antigens immunity, active
flidvax2006Immunity, activeexperimentalVaccineTumor antigens immunity, active
fluma peptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
fsp peptidesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
gave melanomaImmunity, activeexperimentalVaccineTumor antigens immunity, active
gen-1Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
gene-modified tumor cell vaccine therapyImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
genevax il-12-4532Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
geniusvac-mel4Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
gm-k562 cell vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
gp75 dna vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
gp96-ig vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigens
grnvac1Immunity, activeexperimentalVaccineimmunity, active - tumor antigen
gsk 249553Immunity, activeexperimentalVaccineTumor antigens immunity, active
gsk2241658aImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
gsk2302025aImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
gsk2302032aImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
gvax lung cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
gvax pancreatic cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
gvax prostate cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
gx-188eImmunity, activeexperimentalVaccineTumor antigens immunity, active
h1299 lysate vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hepcortespenlisimut-l (Hepko V5)Immunity, activeexperimentalVaccineTumor antigens immunity, active
her2-peptid-vakzineImmunity, activeexperimentalVaccineTumor antigens immunity, active
hla-a*02:01-restricted vegfr1-derived peptide vaccinationImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*0201 or hla-a*0206-restricted urlc10 peptidesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*0201restricted urlc10 peptides with adjuvantImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402 or a*0201 restricted peptidesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402-restricted cdca1 and kif20a peptidesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402restricted urlc10, cdca1, and kif20a peptidesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402restricted urlc10, cdca1, and kif20a peptides with adjuvantImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402restricted urlc10, cdca1, vegfr1 and vegfr2Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a*2402restricted urlc10, ttk, vegfr1 and vegfr2Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a02 restricted hig2Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hodgkin's antigens-gm-csf-expressing cell vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hs-410Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
hsp110-gp100 chaperone complex vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
htert i540/r572y/d988y multipeptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
htert/survivin multi-peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
hyperacuteImmunity, activeexperimentalVaccineimmunity, active - tumor antigen
hyperacute-lung cancer vaccineImmunity, activeexperimentalBiologicalTumor antigens immunity, active
hyperacute-melanoma vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
hyperacute-prostate cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
hyperacute-renal cancer vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
ict-107Immunity, activeexperimentalVaccineTumor antigens immunity, active
id-lv305Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
idc-g305Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
idh1 peptide vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigens
igf-1r/as odnImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
il-2 and human cd40 ligand plasmid gene modified autologous tumor cellsImmunity, activeexperimentalVaccineTumor antigens immunity, active
il15-dc vaccineImmunity, activeexperimentalCell therapyimmunity, active - tumor antigens
ima101Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ima950Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ino-9012Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
inxn-3001Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
it-pil12-epImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ivac_w_bre1_uidImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
jnj-64041809Immunity, activeexperimentalVaccineTumor antigens immunity, active
klh-id vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
krn7000 loaded dendritic cellsImmunity, activeexperimentalVaccineTumor antigens immunity, active
l-vaxImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
lipo-meritImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
lipovaxinImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
lung tumor associated antigenImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ly6k, vegfr1, vegfr2Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
m-vaxImmunity, activeexperimentalVaccineTumor antigens immunity, active
mage-12 peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mage-a1, mage-a3, and ny-eso-1 vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mage-a10 peptideImmunity, activeexperimentalBiologicalTumor antigens immunity, active
mammaglobin-a dna vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mart-1, gp100, tyrosinase peptidesImmunity, activeexperimentalVaccineTumor antigens immunity, active
Maveropepimut SImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
melan-a analog peptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
melanoma vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
melitac 12.1 peptide vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
mg1-magea3Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
mg1ma3Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
mgn1601Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
mkc1106Immunity, activeexperimentalVaccineTumor antigens immunity, active
mouse tyrosinaseImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mouse tyrp2 dnaImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mrna coding for melanoma associated antigensImmunity, activeexperimentalVaccineTumor antigens immunity, active
mrna from psa, pap, survivin and htert transfected dendritic cellImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mrna/protaminImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
muc-2-globo h-klh conjugate vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
multi-epitope melanoma peptide vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
mva-bn-her2Immunity, activeexperimentalVaccineTumor antigens immunity, active
mva-bn-proImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mva-brachyury-tricomImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
mva.5t4Immunity, activeexperimentalBiologicalTumor antigens immunity, active
myeloma immunoglobulin idiotype vaccineImmunity, activeexperimentalBiologicalTumor antigens immunity, active
myeloma immunoglobulin idiotype vaccine-klhImmunity, activeexperimentalVaccineTumor antigens immunity, active
neo-pv-01Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
neovaxImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
npmw-peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ny-eso-1 proteinImmunity, activeexperimentalVaccineimmunity, active - tumor antigen
ocpm immunotherapeutic vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigens
oncoquestImmunity, activeexperimentalVaccineTumor antigens immunity, active
oncovaxImmunity, activeexperimentalBiologicalTumor antigens immunity, active
ont-10Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ose2101Immunity, activeexperimentalVaccineTumor antigens immunity, active
otsgc-a24Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
ova bip peptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
ovarian cancer peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
p10s-padre vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
p16_37-63Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
p501-as15 vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
p946Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
p946/tet-pImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pa-1-stk ovarian carcinoma vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pbcar3-phosphopeptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pek fusion protein vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pep-3-klhImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pep03Immunity, activeexperimentalVaccineTumor antigens immunity, active
personalized neoantigen vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
personalized polyepitope dna vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pf-06755990Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
pf-06755992Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
pgv001Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
pirs2-phosphopeptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
polyvalent antigen-klh conjugate vaccineImmunity, activeexperimentalBiologicalTumor antigens immunity, active
precision multiple antigen t cellImmunity, activeexperimentalCell therapyimmunity, active - tumor antigens
prostvac-v/tricomImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
proteasome sirna and tumor antigen rna-transfected dendritic cellsImmunity, activeexperimentalVaccineTumor antigens immunity, active
psa prostate cancer vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pumvc3-igfbp2-her2-igf1rImmunity, activeexperimentalVaccineTumor antigens immunity, active
pvax/l523sImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pvaxrcpsav53lImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
pxfk peptideImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
rf-cea(6d)/tricomImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
rf-go 100p209Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
rfusin2-aml1Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
rna-loaded dendritic cell vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
rnf43, tomm34, vegfr1, vegfr2 peptide vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigens
s-488410Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
s-588210Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
s-588410Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvantImmunity, activeexperimentalBiologicalTumor antigens immunity, active
sb-as15Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
scib1Immunity, activeexperimentalVaccineimmunity, active - tumor antigens
sknlp vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
survivin peptide vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
survivin-peptide double loaded dendritic cellsImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
svn53-67/m57-klh peptide vaccineImmunity, activeexperimentalBiologicalimmunity, active - tumor antigens
synthetic melanoma associated epitopesImmunity, activeexperimentalVaccineTumor antigens immunity, active
synthetic tumor-associated peptide vaccine therapyImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
tapa-pulsed dendritic cellsImmunity, activeexperimentalVaccineTumor antigens immunity, active
tergenpumatucel-lImmunity, activeexperimentalCell therapyimmunity, active - tumor antigens
tetanus peptide melanoma vaccineImmunity, activeexperimentalVaccineTumor antigens immunity, active
tf(c)-klh conjugate vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
theravacImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
thomsen-friedenreich antigenImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
trivalent ganglioside vaccineImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
unmodified sknlp, with gene-modified sjnb-jf-il2 and sjnb-jf-ltn neuroblastoma cellsImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
vaccinia virus expressing 5 transgenesImmunity, activeexperimentalVaccineimmunity, active - tumor antigens
1rg-cartImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
4h11-28z/fil-12/efgrt+ genetically-modified t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
abgn-107Immunity, passiveexperimentalmAbTumor antigens immunity, passive
akti-treated tilImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
alecsatImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
anti-mart-1 f5 tcr pblImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
anti-ny eso-1 tcr-transduced t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigen
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014Immunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
autologous anti-mart-1 f5 t-cell receptorImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
autologous anti-mart-1 f5 t-cell receptor gene-engineered tumor infiltrating lymphocytesImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
autologous tumor infiltrating lymphocytesImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytesImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
car t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigen
cd8 enriched young tilImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
cep-37250Immunity, passiveexperimentalmAbTumor antigens immunity, passive
cu64-dota b-fabImmunity, passiveexperimentalmAbTumor antigens immunity, passive
dendritic cell activated cytokine-induced killer cellImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
dmf5 melanoma reactive tilImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
dta-h19Immunity, passiveexperimentalBiologicalimmunity, passive - tumor antigens
ex vivo-expanded her2-specific t cellsImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
favldImmunity, passiveexperimentalVaccineTumor antigens immunity, passive
hua33Immunity, passiveexperimentalmAbTumor antigens immunity, passive
icaspase9-transduced t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
il-12 transduced tilImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
m170Immunity, passiveexperimentalmAbTumor antigens immunity, passive
mart-1 reactive cd8+ pblImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
mov18 igeImmunity, passiveexperimentalmAbTumor antigens immunity, passive
ny-eso-1, magea4, prame, survivin and ssx - specific t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
oregovomabImmunity, passiveexperimentalmAbTumor antigens immunity, passive
prame/ssx/mage-specific t cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
rm28Immunity, passiveexperimentalmAbTumor antigens immunity, passive
stem cells treated with the anti-b7 antibodiesImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
tc-nk cellsImmunity, passiveexperimentalCell therapyimmunity, passive - tumor antigens
tgfbdnrii-transduced autologous tumor infiltrating lymphocytesImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
tumor specific antigen induced cytotoxic lymphocyteImmunity, passiveexperimentalCell therapyTumor antigens immunity, passive
poractant alfa (curosurf)SurfactantapprovedAnimal productTumor antigens surfactant